Αποτελέσματα αναζήτησης - "РиоФлора Баланс Нео"

1

Academic Journal

АНТИБИОТИК-АССОЦИИРОВАННАЯ ДИАРЕЯ: АКТУАЛЬНОСТЬ ПРОБЛЕМЫ, ПРОФИЛАКТИКА И ТЕРАПИЯ

Συγγραφείς: Ю. П. Успенский, Ю. А. Фоминых

Συνεισφορές: компания "Никомед Такеда"

Πηγή: The Russian Archives of Internal Medicine; № 2 (2013); 46-53 ; Архивъ внутренней медицины; № 2 (2013); 46-53 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2013-0-2

Θεματικοί όροι: РиоФлора Баланс Нео, side effects, antibiotic-associated diarrhea, prophylaxis, therapy, multispecies probiotics, RioFlora Balance Neo, побочные эффекты, антибиотик-ассоциированная диарея, профилактика, лечение, мультивидовые пробиотики

Περιγραφή αρχείου: application/pdf

Relation: https://www.medarhive.ru/jour/article/view/354/355; Вялов С.С., Бакулин И.Г., Хурасева А.Б., Яковлев А.А. Эффективность комплексных пробиотиков при запорах у беременных женщин // «Архивъ внутренней медицины». 2013; 1(9): С. 14–18.; Самсонов А.А., Плотникова Е.Ю. Антибиотики: друзья или враги, как найти консенсус? Взгляд гастроэнтеролога на антибиотик-ассоциированную диарею // Трудный пациент 2012. No6.С.16-24.; Шевяков М.А. Антибиотик-ассоциированная диарея и кандидоз кишечника: возможности лечения и профилактики // Антибиотики и химиотерапия. 2004. Т. 49. No 1(9). С. 26–29.; Шендеров Б.А. Медицинская микробная экология и функциональное питание. Т.3. Пробиотики и функциональное питание. М.: Изд-во Грантъ. 2001. 287 с.; Avesani V., Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection // Infect Immunol 1994; 62: 384–389.; Bartlett J.G. Antibiotic-associated diarrhea // Clin Infect Dis 1992. Vol. 15: 573–81.; Bulusu M., Narayan S., Shetler K., Triadafilopoulos G. Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea // Am J Gastroenterol 2000; 95: 3137–3141.; Cremonini F. et al. Meta–analysis: the effect of probiotic administration on antibiotic–associated diarrhoea // Aliment Pharmacol Ther. 2002. Vol. 16 (8). Р. 1461–1467.; Fekety R. Guidelines for the diagnosis and management of Clostridium difficile–associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee // Am J Gastroenterol 1997. Vol. 92. Р. 739–750.; Fekety R., Silva J., Kauffman C. et al: Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens // Am. J. Med. 1989. Vol. 86. Р. 15–19.; Fredenucci I., Chomarat M., Boucaud C., Flandrois J.P. Saccharomyces boulardii fungemia in a patient receiving ultra-levered therapy // Clin Infect Dis 1998. Vol. 27 (1). Р. 222–223.; Gilbert D.N. Aspects of the safety profile of oral antimicrobial agents // Infect Dis Clin Pract 1995. Vol. 4(2). Р. 103–112.; Guzman R., Kirkpatrick J., Forward K., Lim F. Failure of parenteral metronidazole in the treatment of pseudomembranous colitis // J Infect Dis 1989. Vol. 159. Р. 1154–1155.; Hempel S., Newberry S.J., Maher A.R. et al. Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea. A Systematic Review and Meta-analysis // JAMA 2012. Vol. 307 (18). Р. 1959–1969.; Hogenauer C., Hammer H.F., Krejs G.J., Reisinger E.C. Mechanisms and management of antibiotic-associated diarrhea // Clinical Infec- tious Diseases 1998. Vol. 27 (4). Р. 702–710.; Hogenauer C., Langner C., Krause R. et al. Antibiotic-associated segmental hemorrhagic colitis: clinical features, and influence of Klebsiella oxytoca in its pathogenesis // Abstracts of 12 UEGW, Gut 2004. Vol. 53 (VI). Р. A135.; Idem А. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea // Lancet 2001. Vol. 357. Р. 189–93.; Koning C.J., Jonkers D.M., Stobberingh E.E., Mulder L., Rombouts F.M., Stockbrugger R.W. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxicillin // The Am J Gastroenterol. 2008. . Vol. 103. Р. 178–189.; Kyne L., Warny M., Qamar A., Kelly C.P. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A // N Engl J Med 2000; 342. Р. 390–7.; Land M.H., Rouster-Stevens K., Woods C.R. et al. Lactobacillus sepsis associated with probiotic therapy // Pediatrics 2005; 115 (1). Р. 178–181.; Lestin F., Pertschy A., Rimek D. Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities // Dtsch MedWochenschr 2003; 128 (48). Р. 2531–2533.; McFarland L.V. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea // Dig Dis 1998; 16: 292–307.; McFarland L.V. Meta-analysis of probiotics for the prevention of an- tibiotic associated diarrhea and the treatment of Clostridium difficile disease // Am J Gastroenterol 2006. Vol. 101 (4). Р. 812–822.; McFarland L.V., Mulligan M.E., Kwok R.Y.Y., Stamm W.E. Nosocomial acquisition of Clostridium difficile infection // N Engl J Med 1989. Vol. 320: 204–210.; Piechno S., Seguin P., Gangneux J.P. Saccharomyces boulardii fungal sepsis: beware of the yeast // Can J Anaesth 2007; 54 (3). Р. 245–246.; Riggs M.M., Sethi A.K., Zabarsky T.F. et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents // Clin Infect Dis 2007. Vol. 45. Р. 992.; Riquelme A.J., Calvo M.A., Guzma ́n A.M. et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients // J Clin Gastroenterol 2003. Vol. 36 (1). Р. 41–43.; Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomized, placebo-controlled trials // Lancet Infect. Dis. Vol. 6. P. 374-382.; Starr J. Clostridium difficile-associated diarrhoea: diagnosis and treatment // BMJ 2005. Vol. 331: 498–501.; Trautmann M., Synowzik I., Nadji-Ohl M. et al. Fungemia due to Saccharomyces cerevisiae var boulardii. // Chemotherapie Journal 2008. Vol. 17 (2). Р. 57–61.; Wistrom J., Norrby S.R., Myhre E.B. et al. Frequency of antibiotic- associated diarrhea in 2462 antibiotic-treated hospitalized patients: a prospective study // Journal of Antimicrobial Chemotherapy 2001. Vol. 47. Р. 43–50.; Zunic P., Lacotte J., Pegoix M. et al. Saccharomyces boulardii funge- mia // Therapie 1991. Vol. 46 (6). Р. 498–499.; https://www.medarhive.ru/jour/article/view/354

Διαθεσιμότητα: https://www.medarhive.ru/jour/article/view/354
https://doi.org/10.20514/2226-6704-2013-0-2-46-53

View record from BASE

2

Academic Journal

ВЛИЯНИЕ ПРОБИОТИКА РИОФЛОРА БАЛАНС НЕО НА МЕТАБОЛИЧЕСКУЮ АКТИВНОСТЬ МИКРОФЛОРЫ КИШЕЧНИКА

Συγγραφείς: И. А. Ли, С. Ю. Сильвестрова, Е. В. Трейман, В. Н. Дроздов

Συνεισφορές: компания Takeda

Πηγή: The Russian Archives of Internal Medicine; № 4 (2013); 61-67 ; Архивъ внутренней медицины; № 4 (2013); 61-67 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2013-0-4

Θεματικοί όροι: РиоФлора Баланс Нео, butyrate, fatty acids, RioFlora Balance Neo, кишечная микрофлора, бутират, жирные кислоты

Περιγραφή αρχείου: application/pdf

Relation: https://www.medarhive.ru/jour/article/view/210/208; Албертс Б., Брей Д., Льюс Д. и др. Молекулярная биология клетки, тт. 1–3. М., 1994.; Ардатская М.Д. Клиническое значение короткоцепочечных жирных кислот при патологии желудочно-кишечного тракта. Дис. … д-ра мед. наук. М., 2003.; Арутюнян Э.Э., Ардатская М.Д., Минушкин О.Н. Изучение короткоцепочечных жирных кислот у больных неспецифическим язвенным колитом // Кремлевск. мед. 2002. № 1. С. 21–25.; Василенко В.В. Дисбактериоз — синдром раздражённого кишечника: эссе-анализ проблемы // Рос. журн. гастроэнтерол., гепатол., колопроктол. 2000. № 6. С. 10–13.; Дубинин А.В., Бабин В.Н., Раевский П.М. Трофические и регуляторные связи макроорганизма и микрофлоры // Клин. мед. 1991. № 7. С. 24–28.; Метаболизм бактерий. Пер. с англ., под ред. И. Ганзалус, Р. Стайнер, М.: Издат. Ин. лит., 1963.; Минушкин О.Н., Ардатская М.Д., Бабин В.Н. и др. Дисбактериоз кишечника // Рос. мед. журн. 1999. № 3. С. 40–45.; Парфёнов А.И. Энтерология на рубеже ХХ и ХХI веков // Рос. журн. гастроэнтерол., гепатол., колопроктол. 2004. № 3. С. 41–44.; Agarwal V.P., Schimmel E.M. Diversion colitis: a nutritional deficiency syndrome? // Nutr. Rev. 1989. Vol. 47. P. 257–261.; Albert M.J., Bhat P., Rajan D. et al. Faecal flora of South Indian infants and young children in health and with acute gastroenteritis // J. Med. Microbiol. 1978. Vol. 11. P. 137–143.; Archer S.Y., Meng S., Shei A. et al. p21 (WAF1) is required for butyratemediated growth inhibition of human colon cancer cells // Proc. Natl. Acad. Sci. USA. 1998. Vol. 95. P. 6791–6796.; Bartram H.P., Scheppach W., Schmid H. et al. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia and pH // Cancer Res. 1993. Vol. 53. P. 3283–3288.; Boffa L.C., Lupton J.R., Mariani M.R. et al. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short-chain fatty acids by variation of dietary fiber (wheat bran) in rats // Cancer Res. 1992. Vol. 52. P. 5906–5912.; Clausen M.R., Bonnen H., Tvede M., Mortensen P.B. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 1991; 101: 1497-1504.; Cummings J.H., Englyst H.N. Fermentation in the human large intestine and the available substrates // Am. J. Clin. Nutr. 1987. Vol. 45. P. 1243–1255.; Domon-Dell C., Wang Q., Kim S. et al. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells // Gut. 2000. Vol. 50. P. 525–529.; Gibson G.R., Macfarlane G.T. (eds.) Human colonic bacteria: role in nutrition, physiology and pathology // CRC Press. 1995. P. 1–18.; Gibson P.R., Folino M., Rosella O. et al. Effects of dietary fibre on colonic mucosal characteristics in rats // Gastroenterology. 1993. Vol. 104. P. 405.; Gorbach S.L., Banwell J.G., Chatterjec B.D. et al. Acute undifferentiated human diarrhea in the tropic.1. Alterations in intestinal microflora // J. Clin. Invest. 1977. Vol. 50. P. 881–889.; Guillemot F., Colombel J.F., Neut C. et al. Treatment of diversion colitis by short-chain fatty acids: prospective and double-blind study // Dis. Colon. Rectum. 1991. Vol. 34. P. 861–864.; Hague A., Diaz G.D., Hicks D.J. et al. Bcl-2 and bak may play a pivotal role in sodium butyrate – induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis // Int. J. Cancer. 1997. Vol. 72. P. 898–905.; Hague A., Elder D.J., Hicks D.J. et al. Apoptosis in colorectal tumor cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate // Int. J. Cancer. 1995. Vol. 60. P. 400–406.; Harig J.M., Soergel K.H., Komorowski R.A. et al. Treatment of diversion colitis with short-chain fatty acid irrigation // N. Engl. J. Med. 1989. Vol. 320. P. 23–28.; Harris W.S., Counor W.E., Jukeles B.B. // Metabolism. 1984. Vol. 33. P. 1016–1019.; Heimdahl A., Nord C.E. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract // Eur. J. Clin. Microbiol. 1982. Vol. 1. P. 38–48.; Hoverstad T., Carlstedt-Duke B., Lingaas E. et al. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects // Scand. J. Gastroenterol. 1986. Vol. 21. P. 621–626.; Liu M.S., Ghosh S., Yang Y. Change in membrane lipid fluidity induced by phospholipase A. activation: a mechanism of endotoxic shock // Life Sci. 1983. Vol. 33. P. 1995–2002.; Macfarlane G.T., Gibson G.R., Beatty E.R., Cummings J.H. Estimation of short-chain fatty acid production from protein by human intestinal bacterial based on branched chain fatty acid measurements // FEMS Microbiol. Ecol. 1992. Vol. 101. P. 81–88.; Mariadason J.M., Velcich A., Wilson A.J. et al. Resistance to butyrateinduced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation // Gastroenterology. 2001. Vol. 120. P. 889–899.; Mortensen P.B., Clausen M.R. Antibiotic-associated diarrhoea. In: Binder H.J., Cummings J., Soergel K. (eds). Short chain fatty acid. Kluwer Academic Publishers, 1994. P. 240–247.; Niles R.M., Wilhelm S.A., Thomas P., Zamcheck N. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation // Cancer Invest. 1988. Vol. 6. P. 39–45.; Ramakrishna B.S., Mathan V.I. Colonic dysfunction in acute diarrhea: the role of luminal short chain fatty acids // Gut. 1993. Vol. 34. P. 1215–1218.; Royall D., Wolever T.M.S., Jeejeebhoy K.N. Clinical significance of colonic fermentation // Am. J. Gastroenterol. 1990. Vol. 85. P. 1307–1312.; Salminen S., Isolauri E., Onela T. Gut flora in normal and disordered states // Chemotherapy. 1995. Vol. 41, Suppl. 1. P. 5–15.; Scheppach W., Sommer H., Kirchner T. et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis // Gastroenterology. 1992. Vol. 103. P. 51–56.; Siliprandi N., Di Lisa F., Menabo R. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism // Cardiovasc. Drugs. Ther. 1991. Vol. 5. P. 11–16.; Stephen A.M. Propionate and its role in lipid metabolism / SCFAs and metabolism // Short Chain Fatty Acides. Congress Short Report Falk Symposium, comp. by W. Scheppach, Strasbourg, 1993, P. 27–28.; Tazume S., Takeshi K., Saidi M. et al. Ecological studies on intestinal microbial flora of Kenyan children with diarrhea // J. Trop. Med. Hyg. 1990. Vol. 93. P. 215–221.; https://www.medarhive.ru/jour/article/view/210

Διαθεσιμότητα: https://www.medarhive.ru/jour/article/view/210
https://doi.org/10.20514/2226-6704-2013-0-4-61-67

View record from BASE

3

Academic Journal